ADXS Market Cap History
Below is a table of the ADXS market cap history going back to 7/15/2013:

Date ADXS Market Cap
7/15/201327.98M
9/6/201320.60M
10/17/201344.99M
1/17/201473.94M
3/13/201467.00M
6/3/201458.79M
9/2/201483.34M
12/26/2014188.45M
3/9/2015348.55M
6/10/2015748.81M
9/9/2015462.45M
2/24/2016193.70M
6/1/2016324.23M
8/31/2016459.40M
1/5/2017316.36M
3/7/2017353.39M
6/2/2017326.53M
8/31/2017279.66M
12/15/2017129.69M
3/8/2018106.20M
6/4/201887.88M
8/31/201876.60M
12/31/201813.24M
2/28/201924.90M
3/29/201927.48M
6/3/201921.42M
9/6/20198.28M
12/16/201932.99M
2/29/202048.80M
6/11/202040.04M
9/2/202029.07M
1/15/202168.30M
3/8/202179.92M

Also see: ADXS Shares Outstanding History
and ADXS YTD Return
ADXS Historical Market Cap:
+14.70% CAGR
ADXS Historical Market Cap: +14.70% CAGR

Mouse over chart for data details
7/15/2013 ...3/8/2021
Advaxis is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) Technology antigen delivery products based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-based strains integrate multiple functions into a single immunotherapy and are designed to access and direct antigen presenting cells to stimulate anti-tumor T cell immunity, activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the Tumor Microenvironment to enable T cells to eliminate tumors. We show 33 historical shares outstanding datapoints in our ADXS shares outstanding history coverage, used to compute ADXS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ADXS market cap history over the course of time is important for investors interested in comparing ADXS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ADXS versus a peer is one thing; comparing ADXS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ADXS can fluctuate over the course of history. With this page we aim to empower investors researching ADXS by allowing them to research the ADXS market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ADXS:
ADXS SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Advaxis (ADXS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AEMD Market Cap History
AERI Market Cap History
AEZS Market Cap History
AGEN Market Cap History
AGIO Market Cap History
AGLE Market Cap History
AGN Market Cap History
AGRX Market Cap History
AGTC Market Cap History
AHPI Market Cap History
More Healthcare companies »

 

ADXS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.